CompletedPhase 4

Levetiracetam for Benign Rolandic Epilepsy

United States6 participantsStarted 2005-03

Plain-language summary

This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.

Who can participate

Age range6 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ages 6-12 * Benign rolandic epilepsy * Language difficulties as reported by parents or teachers * On another anticonvulsant other than levetiracetam Exclusion Criteria: * Prior use of levetiracetam * On 2 or more anticonvulsants * Language problems prior to epilepsy * Another seizure disorder * Status epilepticus within the past 6 months * Significant psychiatric disease * Progressive neurologic disease

What they're measuring

Language improvement

Trial details

NCT IDNCT00181116

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Epilepsy trials